Tanshinone IIA induces apoptosis via inhibition of Wnt/β‑catenin/MGMT signaling in AtT‑20 cells

Li,Zong‑Yang; Huang,Guo‑Dong; Chen,Lei; Zhang,Ce; Chen,Bao‑Dong; Li,Qing‑Zhong; Wang,Xiang; Zhang,Xie‑Jun; Li,Wei‑Ping

doi:10.3892/mmr.2017.7325

Tanshinone IIA induces apoptosis via inhibition of Wnt/β‑catenin/MGMT signaling in AtT‑20 cells

Authors:
- Zong‑Yang Li
- Guo‑Dong Huang
- Lei Chen
- Ce Zhang
- Bao‑Dong Chen
- Qing‑Zhong Li
- Xiang Wang
- Xie‑Jun Zhang
- Wei‑Ping Li
View Affiliations

Affiliations: Brain Center, Shenzhen Key Laboratory of Neurosurgery, Shenzhen Second People's Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen, Guangdong 518035, P.R. China
Published online on: August 22, 2017 https://doi.org/10.3892/mmr.2017.7325
Pages: 5908-5914
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A strategy to suppress the expression of the DNA repair enzyme O6‑methylguanine‑DNA methyltransferase (MGMT) by inhibition of Wnt/β‑catenin signaling may be useful as a novel treatment for pituitary adenoma. Previous studies have reported that Tanshinone IIA (TSA), a major quinone compound isolated from Salvia miltiorrhiza, had antitumor effects. However, whether TSA has antitumor effects against pituitary adenoma and whether the mechanisms are associated with the Wnt/β‑catenin/MGMT pathway remains to be clarified. In the present study, TSA treatment caused apoptosis in AtT‑20 cells in a concentration‑dependent manner, as demonstrated by cell viability reduction, phophatidylserine externalization detected by Annexin V staining and mitochondrial membrane potential disruption detected by JC‑1 staining, which were associated with activation of caspase‑3 and DNA fragmentation detected by TUNEL in AtT‑20 cells. T‑cell factor (TCF)‑lymphoid‑enhancing factor (LEF) reporter activity was determined by dual luciferase reporter assay and the interaction between β‑catenin and TCF‑4 were detected using a co‑immunoprecipitation kit. The results indicated TSA treatment increased β‑catenin phosphorylation, inhibited β‑catenin nuclear translocation, reduced β‑catenin/TCF‑4 complex formation and TCF‑LEF luciferase reporter activity, and subsequently reduced the expression of cyclin D1 and MGMT. Notably, overexpression of MGMT in β‑catenin knock down AtT‑20 cells abrogated the TSA‑mediated effects in AtT‑20 cells. In conclusion, TSA induced apoptosis via inhibition of Wnt/β‑catenin‑dependent MGMT expression, which may provide novel insights into the understanding of the mechanism of the antitumor effects of Salvia miltiorrhiza.

View Figures

View References

1	Gurcan O, Gurcay AG, Kazanci A, Yildirim AE, Turkoglu OF, Komurcu HF and Beskonakli E: Trigeminal neuralgia as an unusual isolated symptom of pituitary Adenoma: Case report and review of the literature. Turk Neurosurg. 26:180–183. 2016.PubMed/NCBI
2	Bengtsson D, Schrøder HD, Andersen M, Maiter D, Berinder K, Rasmussen U Feldt, Rasmussen ÅK, Johannsson G, Hoybye C, Van Der Lely AJ, et al: Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide. J Clin Endocrinol Metab. 100:1689–1698. 2015. View Article : Google Scholar : PubMed/NCBI
3	McCormack A, Kaplan W, Gill AJ, Little N, Cook R, Robinson B and Clifton-Bligh R: MGMT expression and pituitary tumours: Relationship to tumour biology. Pituitary. 16:208–219. 2013. View Article : Google Scholar : PubMed/NCBI
4	Chen YP, Hou XY, Yang CS, Jiang XX, Yang M, Xu XF, Feng SX, Liu YQ and Jiang G: DNA methylation and histone acetylation regulate the expression of MGMT and chemosensitivity to temozolomide in malignant melanoma cell lines. Tumour Biol. 37:11209–11218. 2016. View Article : Google Scholar : PubMed/NCBI
5	Wickström M, Dyberg C, Milosevic J, Einvik C, Calero R, Sveinbjörnsson B, Sandén E, Darabi A, Siesjö P, Kool M, et al: Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents. chemoresistance. 6:89042015.
6	Khattak MN, Buchfelder M, Kleindienst A, Schöfl C and Kremenevskaja N: CRH and SRIF have opposite effects on the Wnt/β-catenin signalling pathway through PKA/GSK-3β in corticotroph pituitary cells. Cancer Invest. 28:797–805. 2010. View Article : Google Scholar : PubMed/NCBI
7	Das A, Miller R, Lee P, Holden CA, Lindhorst SM, Jaboin J, Vandergrift WA III, Banik NL, Giglio P, Varma AK, et al: A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway. Tumour Biol. 36:7027–7034. 2015. View Article : Google Scholar : PubMed/NCBI
8	Xing Y, Tu J, Zheng L, Guo L and Xi T: Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells. Oncol Rep. 33:163–170. 2015. View Article : Google Scholar : PubMed/NCBI
9	Bai Y, Zhang L, Fang X and Yang Y: Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB. Exp Ther Med. 11:1085–1089. 2016. View Article : Google Scholar : PubMed/NCBI
10	Prokhorova EA, Zamaraev AV, Kopeina GS, Zhivotovsky B and Lavrik IN: Role of the nucleus in apoptosis: Signaling and execution. Cell Mol Life Sci. 72:4593–4612. 2015. View Article : Google Scholar : PubMed/NCBI
11	Jellinger KA: Challenges in neuronal apoptosis. Curr Alzheimer Res. 3:377–391. 2006. View Article : Google Scholar : PubMed/NCBI
12	Hunter AL, Choy JC and Granville DJ: Detection of apoptosis in cardiovascular diseases. Methods Mol Med. 112:277–289. 2005.PubMed/NCBI
13	Ding L, Ding L, Wang S, Wang S, Wang W, Wang W, Lv P, Lv P, Zhao D, Zhao D, et al: Tanshinone IIA affects autophagy and apoptosis of glioma cells by inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway. Pharmacology. 99:188–195. 2017. View Article : Google Scholar : PubMed/NCBI
14	Huang ST, Huang CC, Huang WL, Lin TK, Liao PL, Wang PW, Liou CW and Chuang JH: Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction. Sci Rep. 7:403822017. View Article : Google Scholar : PubMed/NCBI
15	Yu J, Wang X, Li Y and Tang B: Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1. Oncol Rep. 37:1394–1400. 2017. View Article : Google Scholar : PubMed/NCBI
16	Clevers H: Wnt/beta-catenin signaling in development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
17	Wickström M, Dyberg C, Milosevic J, Einvik C, Calero R, Sveinbjörnsson B, Sandén E, Darabi A, Siesjö P, Kool M, et al: Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. Nat Commun. 6:89042015. View Article : Google Scholar : PubMed/NCBI
18	Formosa R, Gruppetta M, Falzon S, Santillo G, DeGaetano J, Xuereb-Anastasi A and Vassallo J: Expression and clinical significance of Wnt players and survivin in pituitary tumours. Endocr Pathol. 23:123–131. 2012. View Article : Google Scholar : PubMed/NCBI
19	Maïza JC and Caron P: Pituitary carcinomas and aggressive adenomas: An overview and new therapeutic options. Ann Endocrinol (Paris). 70 Suppl 1:S12–S19. 2009.(In French). View Article : Google Scholar : PubMed/NCBI
20	Huang BY, Cao LY and Fu XG: Effects of tanshinone IIA on Wnt/beta-catenin signaling pathway of high glucose induced renal tubular epithelial cell transdifferentiation. Zhongguo Zhong Xi Yi Jie He Za Zhi. 32:965–969. 2012.(In Chinese). PubMed/NCBI